Tuesday, June 30, 2015
AnaptysBio Names Board Members
San Diego-based therapeutic antibody developer AnaptysBio announced this morning that it hass named two new board members. AnaptysBio said it added Hollings Renton--the former CEO and president of Onyx Pharmaceuticals-- and John Schmid--former CFO of Auspex Pharmaceuticals--to add strategic plannning and corporate finance exertise to the company's board. Renton also served at Chiron Corporation, Cetus Corporation, and is currently onn the boards of Portola Pharmaceuticals, Cepheid, and Kythera Biopharmaceuticals. Schmid had also served at Trius Therapeutics, GeneFormatics, Endonetics, and is on the baords of Neos Therapeutics and Speak, Inc.